<html>
<head>PUBMED IDs for TIM3</head>
<body bgcolor='#C5F0F2'><h1>TIM3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12618867/'>Insertion/deletion coding polymorphisms in hHAVcr-1 are not associated with atopic asthma in the Japanese population.</a> March 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14768054/'>SMUCKLER/TIM4 is a distinct member of TIM family expressed by stromal cells of secondary lymphoid tissues and associated with lymphotoxin signaling.</a> February 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16754722/'>Dysregulated T cell expression of TIM3 in multiple sclerosis.</a> June 7  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18294362/'>Significant association between TIM1 promoter polymorphisms and protection against cerebral malaria in Thailand.</a> February 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19566956/'>Lack of association of TIM3 polymorphisms and allergic phenotypes.</a> July 23  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21383193/'>Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker.</a> May 27  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21565238/'>T-cell immunoglobulin and mucin domain 3 genetic polymorphisms are associated with rheumatoid arthritis independent of a shared epitope status.</a> December 21  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22048452/'>TIM polymorphisms--genetics and function.</a> May 1  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22587604/'>TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: impact on disease susceptibility and hepatocellular carcinoma traits.</a> April 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22828168/'>Alterations of specific biomarkers of metabolic pathways in vascular tree from patients with Type 2 diabetes.</a> December 22  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22828147/'>Decreased coronary microvascular reactivity after cardioplegic arrest in patients with uncontrolled diabetes mellitus.</a> October 2  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23291409/'>Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection.</a> August 21  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23554257/'>TIM3 expression by leukemic and non-leukemic myeloblasts.</a> October 31  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25479137/'>Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis.</a> April 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27249753/'>Immunotherapy: Beyond Anti-PD-1 and Anti-PD-L1 Therapies.</a> January 14  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28033288/'>Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma.</a> February 15  2016<br></body></html>
